Secondary Systemic Amyloidosis Latest Advances

Ankylosing spondylitis status and risk of secondary systemic amyloidosis: A two-sample mendelian randomization study.

Journal: Human immunology

Published: September 07, 2023

Systemic amyloidosis with amyloid goiter: An autopsy report.

Journal: Legal medicine (Tokyo, Japan)

Published: August 22, 2022

Outcome of clinical experience of introducing a patient with secondary systemic AL-amyloidosis associated with multiple myeloma.

Journal: Carcinogenesis

Published: August 08, 2022

Gastric perforation caused by secondary systemic amyloidosis.

Journal: Clinical case reports

Published: March 03, 2021

Chronic brucellosis with hepatic brucelloma and AA amyloidosis in a patient with autosomal dominant polycystic kidney disease.

Journal: Autopsy & case reports

Published: May 06, 2019

Secondary systemic amyloidosis diagnosed by endoscopic ultrasound-guided liver biopsy.

Journal: Journal of gastrointestinal and liver diseases : JGLD

Published: March 21, 2018

Secondary systemic amyloidosis in inflammatory bowel disease: a nationwide analysis.

Journal: Annals of gastroenterology

Published: March 17, 2017

Systemic Reactive Amyloidosis Associated with Castleman's Disease.

Journal: Case reports in gastroenterology

Published: December 19, 2013

Effect of infliximab induction therapy on secondary systemic amyloidosis associated with Crohn's disease: case report and review of the literature.

Journal: Journal of gastrointestinal and liver diseases : JGLD

Published: October 01, 2013

Rapidly progressive thyroid mass: amyloid goiter.

Journal: The Journal of craniofacial surgery

Published: November 23, 2012

Incidence and survival in non-hereditary amyloidosis in Sweden.

Journal: BMC public health

Published: May 09, 2012

Effects of secondary amyloidosis on arteriovenous hemodialysis fistula outcomes and intradialytic hypotension: a case-control study.

Journal: Hemodialysis international. International Symposium on Home Hemodialysis

Published: February 25, 2012

Filters

Ankylosing spondylitis status and risk of secondary systemic amyloidosis: A two-sample mendelian randomization study.

Ankylosing spondylitis status and risk of secondary systemic amyloidosis: A two-sample mendelian randomization study.

Systemic amyloidosis with amyloid goiter: An autopsy report.

Systemic amyloidosis with amyloid goiter: An autopsy report.

Outcome of clinical experience of introducing a patient with secondary systemic AL-amyloidosis associated with multiple myeloma.

Outcome of clinical experience of introducing a patient with secondary systemic AL-amyloidosis associated with multiple myeloma.

Gastric perforation caused by secondary systemic amyloidosis.

Gastric perforation caused by secondary systemic amyloidosis.

Chronic brucellosis with hepatic brucelloma and AA amyloidosis in a patient with autosomal dominant polycystic kidney disease.

Chronic brucellosis with hepatic brucelloma and AA amyloidosis in a patient with autosomal dominant polycystic kidney disease.

Secondary systemic amyloidosis diagnosed by endoscopic ultrasound-guided liver biopsy.

Secondary systemic amyloidosis diagnosed by endoscopic ultrasound-guided liver biopsy.

Secondary systemic amyloidosis in inflammatory bowel disease: a nationwide analysis.

Secondary systemic amyloidosis in inflammatory bowel disease: a nationwide analysis.

Systemic Reactive Amyloidosis Associated with Castleman's Disease.

Systemic Reactive Amyloidosis Associated with Castleman's Disease.

Effect of infliximab induction therapy on secondary systemic amyloidosis associated with Crohn's disease: case report and review of the literature.

Effect of infliximab induction therapy on secondary systemic amyloidosis associated with Crohn's disease: case report and review of the literature.

Rapidly progressive thyroid mass: amyloid goiter.

Rapidly progressive thyroid mass: amyloid goiter.

Incidence and survival in non-hereditary amyloidosis in Sweden.

Incidence and survival in non-hereditary amyloidosis in Sweden.

Effects of secondary amyloidosis on arteriovenous hemodialysis fistula outcomes and intradialytic hypotension: a case-control study.

Effects of secondary amyloidosis on arteriovenous hemodialysis fistula outcomes and intradialytic hypotension: a case-control study.